This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Bio-Rad
other brands :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
product type :
antibody
product name :
MOUSE ANTI HUMAN CD9:Alexa Fluor® 700
catalog :
MCA469A700
quantity :
100 TESTS/1 ml
price :
376 USD
clonality :
monoclonal
host :
mouse
conjugate :
AF700
clone name :
MM2/57
reactivity :
human
application :
flow cytometry
product information
EntityType :
Monoclonal Antibody
EntityCategory :
Antibodies
ProductCode :
MCA469A700
Description :
MOUSE ANTI HUMAN CD9:Alexa Fluor® 700
Specificity :
CD9
TargetSpecies :
Human
Host :
Mouse
Format :
ALEXA FLUOR® 700
Conjugate/Tag :
ALEXA FLUOR® 700
Isotypes :
IgG2b
Applications :
F
ApplicationTypes :
Flow Cytometry
CrossReactivities :
Rhesus Monkey,Rabbit,Pig,Mustelid,Bovine,Cat,Dog,Ferret,Llama,Mink,Horse
Clone :
MM2/57
Quantity :
100 TESTS/1 ml
QuantityValue :
100
QuantityType :
TESTS/1ml
GOAccessions :
GO:0007155,GO:0002576,GO:0005515,GO:0030168,GO:0030913,GO:0006928,GO:0007342,GO:0005887,GO:0031092
GOTerms :
alpha-2 macroglobulin receptor-associated protein activity,GO:0045308,protein amino acid binding,protein degradation tagging activity,protein folding chaperone,protein tagging activity,platelet exocytosis,cell adhesion molecule activity,cell movement,cellular component motion,sperm-oocyte fusion,blood coagulation, platelet activation,paranodal axoglial junction formation,paranodal junction biosynthesis,paranodal junction formation,platelet alpha-granule membrane
UniprotAccessions :
P21926
Gene :
CD9
GeneID URL :
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=928
PublishedSynonyms :
MRP-1
EntityFormats :
ALEXA FLUOR® 488,ALEXA FLUOR® 647,ALEXA FLUOR® 700,Biotin,FITC,Pacific Blue®,Purified,RPE,RPE-ALEXA FLUOR® 647,RPE-ALEXA FLUOR® 750
UNSPSC :
41116161
Concentration :
IgG concentration 0.05 mg/ml
ProductForm :
Purified IgG conjugated to Alexa Fluor 700 - liquid
PriceGBP :
269
PriceEUR :
376
PriceUSD :
376 USD
PriceCHF :
409.84
PriceSEK :
3952
PriceNOK :
4027
PriceDKK :
2805
company information

Bio-Rad
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com1 800 265 7376 (North America)
44 (0)1865 852 700 (Rest of World)
44 (0)1865 852 700 (Rest of World)
headquarters: UK
Bio-Rad is one of the world's leading antibody manufacturers, offering over 12,000 antibodies and related reagents for a focused range of research areas such as immunology, cancer, veterinary research and cell biology through its antibody experts formerly known as AbD Serotec.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.
questions and comments